drugset / Trial / NCT05189145

Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles

NCT05189145

Completed 600 enrolled Alexandria University
RandomizedParallel-groupOpen-labelTreatment

Summary

Hormonal monitoring impact on overall pregnancy rate in frozen embryo transfer (FET)cycles and hence progesterone supplement adjustments remain debatable in current literature. This prospective randomized study aims to investigate the effect of monitoring and follow-up of serum progesterone, estradiol \& luteinizing hormone (LH) levels and progesterone supplement adjustments on pregnancy outcomes for FET in programmed hormonal replacement therapy cycles in comparison with ultrasound only in control group

Timeline

Start
2019-10-01
Primary completion
2021-03-15
Completion
2021-10-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified
Subject Progesterone Other / unclassified 100 mg Intramuscular
Subject Progesterone Other / unclassified 400 mg Intramuscular
Background estradiol valerate Unknown 8 mg Oral

Indications